These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 28099084)

  • 1. Mechanisms and New Strategies for Primary Sjögren's Syndrome.
    Mavragani CP
    Annu Rev Med; 2017 Jan; 68():331-343. PubMed ID: 28099084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BAFF overexpression increases lymphocytic infiltration in Sjögren's target tissue, but only inefficiently promotes ectopic B-cell differentiation.
    Ding J; Zhang W; Haskett S; Pellerin A; Xu S; Petersen B; Jandreski L; Hamann S; Reynolds TL; Zheng TS; Mingueneau M
    Clin Immunol; 2016 Aug; 169():69-79. PubMed ID: 27352977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring BAFF: its expression, receptors and contribution to the immunopathogenesis of Sjögren's syndrome.
    Thompson N; Isenberg DA; Jury EC; Ciurtin C
    Rheumatology (Oxford); 2016 Sep; 55(9):1548-55. PubMed ID: 26790457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B-cell tolerance breakdown in Sjögren's syndrome: focus on BAFF.
    Varin MM; Le Pottier L; Youinou P; Saulep D; Mackay F; Pers JO
    Autoimmun Rev; 2010 Jul; 9(9):604-8. PubMed ID: 20457281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sjögren's syndrome.
    Mavragani CP; Moutsopoulos HM
    Annu Rev Pathol; 2014; 9():273-85. PubMed ID: 24050623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sjögren's syndrome: Old and new therapeutic targets.
    Mavragani CP; Moutsopoulos HM
    J Autoimmun; 2020 Jun; 110():102364. PubMed ID: 31831255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B-cell hyperactivity in primary Sjögren's syndrome.
    Kroese FG; Abdulahad WH; Haacke E; Bos NA; Vissink A; Bootsma H
    Expert Rev Clin Immunol; 2014 Apr; 10(4):483-99. PubMed ID: 24564507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-cell populations and sub-populations in Sjögren's syndrome.
    Hamza N; Bos NA; Kallenberg CG
    Presse Med; 2012 Sep; 41(9 Pt 2):e475-83. PubMed ID: 22841377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of BAFF and BAFF receptors in primary Sjögren's syndrome patients with ectopic germinal center-like structures.
    Carrillo-Ballesteros FJ; Palafox-Sánchez CA; Franco-Topete RA; Muñoz-Valle JF; Orozco-Barocio G; Martínez-Bonilla GE; Gómez-López CE; Marín-Rosales M; López-Villalobos EF; Luquin S; Castañeda-Chávez A; Oregon-Romero E
    Clin Exp Med; 2020 Nov; 20(4):615-626. PubMed ID: 32506205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the Innate Immunity Signaling Pathway in the Pathogenesis of Sjögren's Syndrome.
    Shimizu T; Nakamura H; Kawakami A
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33803026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral blood gene expression profiling in Sjögren's syndrome.
    Emamian ES; Leon JM; Lessard CJ; Grandits M; Baechler EC; Gaffney PM; Segal B; Rhodus NL; Moser KL
    Genes Immun; 2009 Jun; 10(4):285-96. PubMed ID: 19404300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of B cells in Sjögren's syndrome--from benign lymphoproliferation to overt malignancy.
    Jonsson R; Nginamau E; Szyszko E; Brokstad KA
    Front Biosci; 2007 Jan; 12():2159-70. PubMed ID: 17127453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salivary Gland Pathology in Sjögren's Syndrome.
    Campos J; Hillen MR; Barone F
    Rheum Dis Clin North Am; 2016 Aug; 42(3):473-83. PubMed ID: 27431349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct profiles of Sjögren's syndrome patients with ectopic salivary gland germinal centers revealed by serum cytokines and BAFF.
    Szodoray P; Alex P; Jonsson MV; Knowlton N; Dozmorov I; Nakken B; Delaleu N; Jonsson R; Centola M
    Clin Immunol; 2005 Nov; 117(2):168-76. PubMed ID: 16126006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the type I interferon pathway in primary Sjogren's syndrome.
    Mavragani CP; Crow MK
    J Autoimmun; 2010 Nov; 35(3):225-31. PubMed ID: 20674271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B-lymphocytes govern the pathogenesis of Sjögren's syndrome.
    Youinou P; Saraux A; Pers JO
    Curr Pharm Biotechnol; 2012 Aug; 13(10):2071-7. PubMed ID: 22208653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune regulation and B-cell depletion therapy in patients with primary Sjögren's syndrome.
    Abdulahad WH; Kroese FG; Vissink A; Bootsma H
    J Autoimmun; 2012 Aug; 39(1-2):103-11. PubMed ID: 22341852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sjögren's syndrome (SjS)-like disease of mice: the importance of B lymphocytes and autoantibodies.
    Nguyen CQ; Cha SR; Peck AB
    Front Biosci; 2007 Jan; 12():1767-89. PubMed ID: 17127420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [B lymphocytes in Sjögren's syndrome].
    Pers JO; Le Pottier L; Devauchelle V; Saraux A; Youinou P
    Rev Med Interne; 2008 Dec; 29(12):1000-6. PubMed ID: 18403061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of transitional type II B cells in the salivary glands of patients with Sjögren's syndrome.
    Daridon C; Pers JO; Devauchelle V; Martins-Carvalho C; Hutin P; Pennec YL; Saraux A; Youinou P
    Arthritis Rheum; 2006 Jul; 54(7):2280-8. PubMed ID: 16802367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.